ARCHIVES

Mendelsohn Defends ImClone’s Actions And His Role In Development of C225

This article is from The Cancer Letter archive.

Vol. 28 No. 38 | October 18, 2002

Download PDF Visit The Full Archive

Related Articles

Miami HIV Trials Unit Forced To Turn Some Patients Away

January 10, 1992

Duke Halts Third Trial; Coauthor Disputes Claim That Data Validation Was Blinded

October 23, 2009

NIH Panel Outlines Strategies To Manage Adrenal Tumors.

February 22, 2002

FDA Approved 88% Of Cancer Applications Since Oncology Office Opened In 2005.

July 3, 2008

New England Medical Center Discloses Case Of Two Overdoses

April 28, 1995

NCI Must Build a Research Community In Pancreatic Cancer, Review Groups Says.

March 9, 2001